Hottest Stocks (Over $10)	Hottest Stocks ($2-$10)	Biggest Losers (Over $10)	Biggest Losers ($2-$10)	Hottest Industries	Hottest Sectors	EPS / Sales Surprises
Enter Ticker Symbol:   Ticker Lookup Company Quote Company Profile Research Summary EPS Consensus Perspective Insider Transactions Price Performance

Enter any portion of the company’s name to find its corresponding ticker symbol:

Search for :

Zacks Company Profile for Health Catalyst, Inc. (HCAT : NSDQ)

• Company Description    Health Catalyst Inc. is a provider of data and analytics technology and services to healthcare organizations. Health Catalyst Inc. is based in Salt Lake City, Utah. Number of Employees: 1,500

• Price / Volume Information    Yesterday's Closing Price: $2.39 Daily Weekly Monthly 20 Day Moving Average: 527,650 shares Shares Outstanding: 70.73 (millions) Market Capitalization: $169.05 (millions) Beta: 1.69 52 Week High: $7.65 52 Week Low: $2.02 Short Interest Ratio:   % Price Change % Price Change Relative to S&P 500 4 Week -11.15% -11.00% 12 Week -14.03% -15.41% Year To Date 0.00% 0.00%

• Address & Contact Information Street Address Phone / Fax Email Address Web URL 10897 SOUTH RIVER FRONT PARKWAY #300 - SOUTH JORDAN,UT 84095 USA ph: 801-708-6800 fax: - ir@healthcatalyst.com http://www.healthcatalyst.com

• General Corporate Information    Officers Daniel Burton - Chief Executive Officer and Director Jason Alger - Chief Financial Officer John A. Kane - Director Duncan Gallagher - Director Jill Hoggard Green - Director Peer Information Health Catalyst, Inc. (HLIS) Health Catalyst, Inc. (AZTA) Health Catalyst, Inc. (APYI) Health Catalyst, Inc. (RNVA) Health Catalyst, Inc. (HMSY) Health Catalyst, Inc. (LRSI) Industry / Sector / Ticker Info Analyst Coverage: No Industry Group: MEDICAL INFO SYS Sector: Medical CUSIP: 42225T107 SIC: 7370 Fiscal Year Fiscal Year End: December Last Reported Quarter: 09/01/25 Next Expected EPS Date: 02/25/26 Share - Related Items Shares Outstanding: 70.73 Most Recent Split Date: (:1) Beta: 1.69 Market Capitalization: $169.05 (millions)

• EPS Information     • Dividend Information Analyst Coverage: No Dividend Yield: 0.00% Current Fiscal Quarter EPS Consensus Estimate: $-0.03 Indicated Annual Dividend: $0.00 Current Fiscal Year EPS Consensus Estimate: $-0.06 Payout Ratio: Number of Estimates in the Fiscal Year Consensus: 3.00 Change In Payout Ratio: Estmated Long-Term EPS Growth Rate: % Last Dividend Paid: NA - $0.00 Next EPS Report Date: 02/25/26

• Fundamental Ratios P/E Current FY Estimate: - Trailing 12 Months: - PEG Ratio: - Price Ratios Price/Book: 0.51 Price/Cash Flow: 6.78 Price / Sales: 0.53 EPS Growth vs. Year Ago Period: 55.56% vs. Previous Quarter: 50.00% Sales Growth vs. Year Ago Period: -0.04% vs. Previous Quarter: -5.45% ROE 12/31/25 - - 09/30/25 - -6.67 06/30/25 - -7.21 ROA 12/31/25 - - 09/30/25 - -3.21 06/30/25 - -3.28 Current Ratio 12/31/25 - - 09/30/25 - 1.88 06/30/25 - 1.83 Quick Ratio 12/31/25 - - 09/30/25 - 1.88 06/30/25 - 1.83 Operating Margin 12/31/25 - - 09/30/25 - -7.50 06/30/25 - -8.24 Net Margin 12/31/25 - - 09/30/25 - -34.05 06/30/25 - -31.67 Pre-Tax Margin 12/31/25 - - 09/30/25 - -33.75 06/30/25 - -31.53 Book Value 12/31/25 - - 09/30/25 - 4.72 06/30/25 - 4.99 Inventory Turnover 12/31/25 - - 09/30/25 - - 06/30/25 - - Debt-to-Equity 12/31/25 - - 09/30/25 - 0.46 06/30/25 - 0.44 Debt-to-Capital 12/31/25 - - 09/30/25 - 31.34 06/30/25 - 30.34

Powered by Zacks Investment Research ©